Peer review reports
From: High SLFN11 expression predicts better survival for patients with KRAS exon 2 wild type colorectal cancer after treated with adjuvant oxaliplatin-based treatment
Original Submission |
24 Mar 2015 |
Submitted |
Original manuscript
|
|
Author responded |
Author comments
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
|
Reviewed |
Reviewer Report
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Publishing |
23 Oct 2015 |
Editorially accepted |
|
2 Nov 2015 |
Article published |
10.1186/s12885-015-1840-6
|
Learn about peer review